ModivCare Stock Tumbles 58.9% Amid Delayed Q2 Filing and BlackRock Stake

Introduction

ModivCare Inc (NASDAQ: MODV), known in Korean as 모디브케어, is a healthcare services company specializing in supportive care solutions. As of August 21, 2025, its shares closed at $0.7605, reflecting a 58.89% decline year-to-date on a trading volume of 1,848,104 shares on the NASDAQ.

Corporate Structure

ModivCare operates through wholly owned subsidiaries, including ModivCare Solutions, LLC. The organization employs more than 10,000 staff members across the United States, combining clinical, technological, and logistical expertise. Its leadership team includes executives with backgrounds in healthcare management and health-equity advocacy. ModivCare partners with payors, providers, and third-party vendors, including Corporate Cost Control for employment verification services.

Healthcare Solutions by Greg Rosenke

Developments and News

• On August 21, 2025, ModivCare filed an SEC Form 8-K (Acc-no: 0001437749-25-027478) covering material events under Items 1.01–9.01.
• On August 12, 2025, the company submitted a Form NT 10-Q (Acc-no: 0001220754-25-000055) to notify the SEC of its inability to timely file the quarterly report for the period ended June 30, 2025; it expects to submit the Form 10-Q within the appropriate grace period.
• On July 17, 2025, BlackRock, Inc. amended its Schedule 13G/A to report beneficial ownership of 317,720 shares, or 2.2% of ModivCare’s common stock, with sole voting and dispositive power over those shares.

Financial and Strategic Analysis

For the trailing twelve months through June 30, 2025, ModivCare reported:

• Revenue of $2.75 billion and a net loss of $229.36 million (–8.33% profit margin)
• Diluted EPS of –$16.09 and return on assets of 0.42%
• Total cash of $115.96 million and a leveraged free cash flow of –$72.89 million

At an enterprise value of $1.31 billion, the company trades at EV/Revenue of 0.48 and EV/EBITDA of 5,250. Its price/sales ratio is 0.01.

Strategically, ModivCare employs a technology-driven model to coordinate non-emergency medical transportation (NEMT), personal in-home assistance, chronic care management, and remote patient monitoring. Company-reported metrics indicate over 35 million rides per year with a 98%+ on-time rate, a 59% increase in member engagement programs, and a 40–60% reduction in emergency room visits for high-risk members.

Market Position and Industry Context

ModivCare is recognized for addressing social determinants of health by integrating transportation, nutrition, and caregiving services under managed care contracts. The company has expanded operations in response to Medicaid expansion and growth among managed care organizations, utilizing proprietary software and data analytics. Competitors in the NEMT and home care sectors include various private operators and health plans offering bundled services. The company's scale and breadth of network are considerable; however, profitability will depend on operational efficiencies, ongoing contract renewals, and regulatory developments in healthcare reimbursement.

tl;dr

On August 21, 2025, ModivCare closed at $0.7605 (–58.89% YTD). The company filed an 8-K and notified the SEC of a delayed Q2 10-Q, anticipating submission within the allowed grace period. BlackRock holds 2.2% of shares. Fiscal 2025 results show $2.75 billion in revenue, $229 million net loss, and $116 million in cash. ModivCare’s technology-focused NEMT and care solutions aim to achieve efficient service delivery and cost management. Full Q2 financials will provide further insight into the company's performance.